Health-Related Quality of Life in Patients with Primary Adrenal Insufficiency
Open Access
- 22 November 2023
- journal article
- research article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 12 (23) , 7237
Abstract
(1) Background: Patients with primary adrenal insufficiency (PAI) suffer from a reduced quality of life. However, clinical factors associated with this impairment remain unclear. The aim of this study was to assess the health-related quality of life (HRQoL) and to evaluate the associations with clinical and hormonal parameters in a group of patients with PAI. (2) Methods: The study included 32 patients with autoimmune PAI, who answered the quality of life in Addison’s disease questionnaire (AddiQoL). Clinical data and hormonal measurements were collected from the patients. (3) Results: The total AddiQoL score of males was significantly higher than that of females (p = 0.011). Furthermore, males reached significantly higher scores in each of the four subscales (fatigue—p = 0.013, emotional sphere—p = 0.048, adrenal insufficiency symptoms—p = 0.039, and miscellaneous questions—p = 0.034). There was a negative correlation between HRQoL and gonadotropin levels (FSH and fatigue r = (−)0.38, p = 0.032; FSH and emotional sphere r = (−)0.416, p = 0.018). This study found no significant associations between AddiQoL scores and the presence of autoimmune comorbidities; only fatigue scores were worse in the presence of autoimmune thyroiditis (p = 0.034). The doses of hydrocortisone and fludrocortisone in the replacement therapy were not associated with AddiQoL scores. AddiQoL scores correlated negatively with the age of diagnosis (p = 0.015). (4) Conclusions: Female sex, higher gonadotropins level, and older age at diagnosis were associated with impaired HRQoL in the studied group of patients with PAI.Keywords
This publication has 25 references indexed in Scilit:
- Impaired health‐related quality of life in Addison's disease – impact of replacement therapy, comorbidities and socio‐economic factorsClinical Endocrinology, 2014
- Continuous Subcutaneous Hydrocortisone Infusion versus Oral Hydrocortisone Replacement for Treatment of Addison's Disease: A Randomized Clinical TrialThe Journal of Clinical Endocrinology & Metabolism, 2014
- What Affects the Quality of Life in Autoimmune Addison's Disease?Hormone and Metabolic Research, 2013
- Quality of Life in European Patients with Addison's Disease: Validity of the Disease-Specific Questionnaire AddiQoLThe Journal of Clinical Endocrinology & Metabolism, 2012
- Influence of hydrocortisone dosage scheme on health‐related quality of life in patients with adrenal insufficiencyClinical Endocrinology, 2010
- Development of a Disease-Specific Quality of Life Questionnaire in Addison’s DiseaseThe Journal of Clinical Endocrinology & Metabolism, 2010
- Long-Term DHEA Replacement in Primary Adrenal Insufficiency: A Randomized, Controlled TrialThe Journal of Clinical Endocrinology & Metabolism, 2008
- Replacement of Dehydroepiandrosterone in Adrenal Failure: No Benefit for Subjective Health Status and Sexuality in a 9-Month, Randomized, Parallel Group Clinical TrialThe Journal of Clinical Endocrinology & Metabolism, 2003
- Improvement in Mood and Fatigue after Dehydroepiandrosterone Replacement in Addison’s Disease in a Randomized, Double Blind TrialThe Journal of Clinical Endocrinology & Metabolism, 2000
- Dehydroepiandrosterone Replacement in Women with Adrenal InsufficiencyNew England Journal of Medicine, 1999